NMR-spectroscopy-based metabonomic approach to the analysis of Bay41-4109, a novel anti-HBV compound, induced hepatotoxicity in rats
Authors:
- 1 September 2007
- journal article
- Published by Elsevier in Toxicology Letters
- Vol. 173 (3) , 161-167
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Interfering with capsid formation: A practicable antiviral strategy against hepatitis B virus?Hepatology, 2004
- Metabonomics technologies and their applications in physiological monitoring, drug safety assessment and disease diagnosisBiomarkers, 2004
- Inhibition of Hepatitis B Virus Replication by Drug-Induced Depletion of NucleocapsidsScience, 2003
- An Integrated Metabonomic Investigation of Acetaminophen Toxicity in the Mouse Using NMR SpectroscopyChemical Research in Toxicology, 2003
- Metabonomics: a platform for studying drug toxicity and gene functionNature Reviews Drug Discovery, 2002
- NMR and Pattern Recognition Studies on the Time-Related Metabolic Effects of α-Naphthylisothiocyanate on Liver, Urine, and Plasma in the Rat: An Integrative Metabonomic ApproachChemical Research in Toxicology, 2001
- The Impact of Genomics-Based Technologies on Drug Safety EvaluationAnnual Review of Pharmacology and Toxicology, 2000
- Dose–response hepatotoxicity of the peroxisome proliferator, perfluorodecanoic acid and the relationship to phospholipid metabolism in ratsToxicology, 1999
- 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic dataXenobiotica, 1999
- Nuclear Magnetic Resonance Spectroscopic and Principal Components Analysis Investigations into Biochemical Effects of Three Model HepatotoxinsChemical Research in Toxicology, 1998